NextPlat Corp has announced the completion of its strategic acquisition of an independent pharmacy in the Pensacola area of northwest Florida. This acquisition, valued at $1,485,439, is expected to bolster the company's growth and profitability in the healthcare sector.
NextPlat Corp, traded on the Nasdaq under the ticker NXPL, operates within the Telephone Communications (No Radiotelephone) industry (SIC 4813). The company focuses on providing healthcare and technology solutions through various channels, including e-commerce and retail. This acquisition is part of a broader strategy to expand its pharmacy footprint and enhance service offerings in underserved markets.
According to the filing, the pharmacy generated approximately $5.6 million in sales for the year ending December 31, 2025. The pharmacy was profitable, maintained positive working capital, and operated with a debt-free balance sheet. This acquisition is anticipated to contribute positively to NextPlat's PharmcoRx healthcare segment throughout the fourth quarter.
David Phipps, CEO of NextPlat, emphasized the strategic importance of the acquisition, stating, "This acquisition synergistically expands our pharmacy footprint in Florida, adding access to the large Pensacola market and to the greater panhandle region where we have an opportunity to rapidly introduce our full array of high-value service offerings to local patients and providers." He further noted that the company is actively exploring additional opportunities to acquire well-established, profitable community operators.
The acquisition may affect various stakeholders, including patients in the Pensacola area, healthcare providers, and competitors in the pharmacy and healthcare markets. NextPlat's PharmcoRx unit currently operates five pharmacies across Florida, providing a range of services from prescription fulfillment to medication management.
Details were not available in the SEC filing regarding any upcoming actions following this acquisition. However, the company is expected to integrate the new pharmacy into its existing network and enhance its service offerings in the region.